RGF Technology

PORT OF PALM BEACH, Fla., Feb. 26, 2021 /PRNewswire/ -- RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of an independent, third-party test that indicates the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater than 99.9% of the SARS-CoV-2 virus in the air and on inoculated surfaces. 

SARS-CoV-2, commonly known as coronavirus, is the virus that causes COVID-19. Given the CDC's determination that SARS-CoV-2 is an airborne virus, meaning it spreads from person-to-person via aerosols and respiratory particles, the test results are important for building owners and operators seeking a proven solution to combat SARS-CoV-2 in the air and on surfaces inside the occupied or air-conditioned space.

"SARS-CoV-2 virus particles or aerosols are produced when an infected person coughs, sneezes or talks.  Large virus particles fall out of the air and onto surfaces, resulting in surface contamination, however small virus particles can stay airborne for hours," noted Dr. James Marsden, Executive Director of Science & Technology at RGF® Environmental Group. "Similar to RGF's REME HALO®, the PHI-PKG14 PHI-CELL® neutralizes greater than 99.9% of the SARS-CoV-2 virus in the air and on contaminated surfaces."

Testing was performed at the Innovative Bioanalysis Laboratories in Cypress, California.  RGF's test procedure used the SARS-CoV-2 virus inside a large chamber (1,280 cu. ft.) representing a real-world air-conditioned office or home. The virus was nebulized into the space simulating a sneeze or cough from an infected person. With the PHI-PKG14 PHI-CELL® operating inside the chamber, the virus was reduced on contact, resulting in a greater than 99.9% reduction of the virus within the simulated real-world space at 36", 72" and 84" distance from the cell.

​